The BIO Convention in China

Thank you for attending the 2013 BIO Convention in China!

Sign up to receive the latest updates about this conference as well as other BIO events.

The BIO Convention in China™ is the premier event where Western biopharma executives and investors explore business and investment opportunities with China’s growing biotech sector and learn more about the changing regulatory landscape from business experts. The event places industry players from North America, Europe and Asia face-to-face with Chinese biopharma business leaders, R&D executives, government officials and entrepreneurs.

BIO is renowned for its successful business development, partnering and investor meetings in North America, Europe and Asia. Partnering at this conference will be powered by BIO One-on-One PartneringTM, an interactive environment to intelligently search, contact and schedule private meetings with potential partners and investors.

The 2012 BIO Convention in China had a diverse representation of attendees and countries, with a strong biotech and pharma presence.
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Download the Program Schedule

>Click here to download the schedule (PDF)<

View or Download the eBrochure

View as a PDF (2.5 MB)

Sign Up For BIO Business Link

Click here to see the archive of BIO Business Link newsletters and to sign up to recieve the newsletter in your inbox.

Recent China Biotech News

•  U.S./China biotech hybrid lands $25M to back global R&D strategy: Article
•  Apexigen lands $20M round as China biotech partners advance antibodies: Article
•  China Biotech In Review: China's Rx Market To Total $315 Billion In 2020: Article
•  Biotech firm’s stem-cell deal could reap rewards in China: Article
•  Dutch firm to set up China Fund to boost biotech sector: Article
•  China Biotech In Review: Simcere Raises $65 Million By Selling Boda Subsidiary: Article
•  Horizon Clinches Landmark Deal in China: Article
•  Mindray Medical of Shenzhen will pay $105 million to acquire Zonare Medical Systems: Article
•  BioDuro opens Shanghai discovery lab: Article
•  China's Biotech Future: Article


Working with the Shanghai Newsummitbio Pharmaceutical Group Co., Ltd., BIO is pleased to offer a unique opportunity to maximize your time in China by attending two industry events, held back-to-back, that will position your organization in front of leading biopharma decision makers, government officials and R&D executives for information exchange, developing new business and networking.

Thanks to all who attended the Fourth Annual China (Taizhou) International Medical Expo on November 8-10, 2013, in Taizhou, Jiangsu. For more information, please contact Kelly Zhang, Shanghai Newsummitbio Pharmaceutical Group Co., Ltd., at [email protected].